Structural and functional studies were performed to assess the membrane act
ions of peptides based on HIV-1 glycoprotein 41,000 (gp41). Previous site-d
irected mutagenesis of gp41 has shown that amino acid changes in either the
N-terminal fusion or N-leucine zipper region depressed viral infection and
syncytium formation, while modifications in the C-leucine zipper domain bo
th increased and decreased HIV fusion. Here, synthetic peptides were prepar
ed corresponding to the N-terminal fusion region (FP-I; gp41 residues 519-5
41), the nearby N-leucine zipper domain (DP-107; gp41 residues 560-597), an
d the C-leucine zipper domain (DP-178; gp41 residues 645-680). With erythro
cytes, FP-I or DP-107 induced dose-dependent hemolysis and promoted cell ag
gregation; FP-I was more hemolytic than DP-107, but each was equally effect
ive in aggregating cells. DP-178 produced neither hemolysis nor aggregation
, but blocked either FP-I- or DP-107-induced hemolysis and aggregation. Com
bined with previous nuclear magnetic resonance and Fourier transform infrar
ed spectroscopic results, circular dichroism (CD) spectroscopy showed that
the alpha -helicity for these peptides in solution decreased in the order:
DP-107 >> DP-178 > FP- I. CD analysis also indicated binding of DP-178 to e
ither DP-107 or FP- I. Consequently, DP-178 may inhibit the membrane action
s mediated by either FP-I or DP-107 through direct peptide interactions in
solution. These peptide results suggest that the corresponding N-terminal f
usion and N-leucine zipper regions participate in HIV infection, by promoti
ng membrane perturbations underlying the merging of the viral envelope with
the cell surface. Further, the C-leucine zipper domain in "prefusion" HIV
may inhibit these membrane activities by interacting with the N-terminal fu
sion and N-leucine zipper domains in unactivated gp41. Last, exogenous DP-1
78 may bind to the N-terminal and N-leucine zipper domains of gp41 that bec
ome exposed on HIV stimulation, thereby preventing the fusogenic actions of
these gp41 regions leading to infection.